Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 15/20 | 0.43 |
| ▸ | CDK9 | P50750 | 14/20 | 0.43 |
| ▸ | CDK7 | P50613 | 6/20 | 0.38 |
| ▸ | CCNH | P51946 | 4/20 | 0.38 |
| ▸ | MNAT1 | P51948 | 4/20 | 0.38 |
| ▸ | CDK4 | P11802 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26340651 | 0.96 | CDK2 (0.43) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL21481510 | 0.94 | CDK2 (0.43) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL26340652 | 0.93 | CDK2 (0.43) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL21481506 | 0.93 | CDK2 (0.42) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL21481475 | 0.93 | CDK2 (0.41) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL21481504 | 0.92 | CDK2 (0.42) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL26340849 | 0.92 | CDK2 (0.44) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL23351995 | 0.91 | CDK2 (0.44) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL27355514 | 0.88 | CDK2 (0.40) | CDK2CDK9CDK7CCNHMNAT1 | |
| SCHEMBL26341871 | 0.88 | CDK2 (0.38) | CDK2CDK9CDK7CCNHMNAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023175173-A1 | CDK7 INHIBITORS FOR ANTIVIRAL TREATMENT | QURIENT CO., LTD. (KR) | 2023-09-21 | — | — | WO | disclosed |